baun health sci j

Balıkesir Sağlık Bilimleri Dergisi

2146-9601 2147-2238

Balıkesir University

Nutritional Science Food Properties Food Nutritional Balance

Beslenme Bilimi Gıda Özellikleri Gıda ve Beslenme Dengesi

Zinc Alpha-2-Glycoprotein Levels and Their Correlations with Obesity in Patients with Major Depressive Disorder

Majör Depresif Bozukluk Tanılı Hastalarda Çinko-Alfa-2-Glikoprotein Düzeyleri ve Obezite ile İlişkisi

https://orcid.org/0009-0009-6489-8327

Arslan

Esra

yüzyıl pendik hastanesi

https://orcid.org/0009-0007-3775-8340

Mutlu

Tuğçin

BALIKESİR ÜNİVERSİTESİ, TIP FAKÜLTESİ

https://orcid.org/0009-0004-0516-2583

Akbaş

Furkan

BALIKESİR ÜNİVERSİTESİ, TIP FAKÜLTESİ

https://orcid.org/0000-0002-3288-2269

Baykan

Hayriye

BALIKESİR ÜNİVERSİTESİ, TIP FAKÜLTESİ

https://orcid.org/0009-0007-7815-0278

Soğucak

Mehmet Orbay

Balıkesir Üniversitesi Tıp Fakültesi

https://orcid.org/0009-0008-4132-0947

Yağcı

Mervan Uğur

BALIKESİR ÜNİVERSİTESİ, TIP FAKÜLTESİ

https://orcid.org/0009-0008-7683-6644

Gül

Meryem

BALIKESİR ÜNİVERSİTESİ, TIP FAKÜLTESİ

https://orcid.org/0000-0001-8551-6900

Baykan

Özgür

BALIKESİR ÜNİVERSİTESİ, TIP FAKÜLTESİ

10 31 2025

14 3 722 728 06 18 2025 09 25 2025

2012

Balıkesir Sağlık Bilimleri Dergisi

Objective: Major depressive disorder (MDD) is the most prevalent mood disorder, presenting a range of psychological, physical, and cognitive symptoms. Diagnosis is a subjective process that predominantly relies on structured clinical interviews. The identification of novel biomarkers could improve diagnostic precision. Zinc alpha-2-glycoprotein (ZAG), a 41–43 kDa glycoprotein present in various tissues and secreted into body fluids, has emerged as a candidate biomarker. This study aims to evaluate the role of ZAG in the differential diagnosis of MDD and its association with obesity. Materials and Methods:The study included 44 patients with MDD and 40 healthy controls. Serum ZAG levels were measured using an ELISA kit. Results: Median ZAG levels were 69.0 (19–150) µg/ml in controls and 32.4 (0.5–150) µg/ml in MDD patients. The difference was not statistically significant. No significant correlation was found between ZAG levels and BMI (p=0.063). A weak negative correlation was observed between ZAG level and MDD (p=0.012, r=-0.272). Conclusion: ZAG levels were lower in MDD patients compared to healthy controls, potentially reflecting the severity of depressive symptoms. Further studies are required to clarify the utility of ZAG as a biomarker for MDD.

Amaç: Majör depresif bozukluk (MDD), çeşitli psikolojik, fiziksel ve bilişsel semptomlarla seyreden en yaygın duygudurum bozukluğudur. Tanısı büyük ölçüde yapılandırılmış klinik görüşmelere dayanan subjektif bir süreçtir. Yeni biyobelirteçlerin tanımlanması, tanısal doğruluğu artırabilir. Çinko alfa-2-glikoprotein (ZAG), çeşitli dokularda bulunan ve vücut sıvılarına salgılanan 41–43 kDa ağırlığında bir glikoprotein olup, potansiyel bir biyobelirteç adayıdır. Bu çalışma, ZAG’ın MDD’nin ayırıcı tanısındaki rolünü ve obezite ile olan ilişkisini değerlendirmeyi amaçlamaktadır. Gereç ve Yöntem:Çalışmaya Balıkesir Üniversitesi Psikiyatri Anabilim Dalı’ndan 44 MDD hastası ve 40 sağlıklı kontrol birey dahil edilmiştir. Serum ZAG düzeyleri ELISA kiti kullanılarak ölçülmüştür. Bulgular: Kontrol grubunda ZAG düzeyleri medyan 69,0 (19–150) µg/ml, hasta grubunda ise 32,4 (0,5–150) µg/ml olarak bulunmuştur. Gruplar arasındaki fark istatistiksel olarak anlamlı bulunmadı. ZAG düzeyleri ile beden kitle indeksi (BKİ) arasında anlamlı bir ilişki bulunmamıştır (P=0,063). ZAG düzeyi ile MDD arasında negatif yönde zayıf korelasyon gözlendi (P=0.012, rs =-0.272). Sonuç: MDD hastalarında ZAG düzeylerinin sağlıklı kontrollere göre daha düşük olduğu görülmüş ve bu durum depresyon şiddetiyle ilişkili olabileceği düşünülmüştür. ZAG’ın MDD için biyobelirteç olarak kullanılabilirliğini netleştirmek amacıyla ileri çalışmalara ihtiyaç vardır.Anahtar Kelimeler: Beden Kitle İndeksi, Majör Depresif Bozukluk, Obezite.

major depressive disorder obesity Body Mass Index

majör depresif bozukluk obezite Beden Kitle İndeksi

Akdemir, A., Türkçapar, M. H., Orsel, S. D., Demirergi, N., Dag, I., & Ozbay, M. H. (2001). Reliability and validity of the turkish version of the hamilton depression rating scale. Comprehensive Psychiatry, 42(2), 161–165. https://doi.org/10.1053/comp.2001.19756

Alberti, A., Araujo Coelho, D. R., Vieira, W. F., Moehlecke Iser, B., Lampert, R. M. F., Traebert, E., Silva, B. B. da, Oliveira, B. H. de, Leão, G. M., Souza, G. de, Dallacosta, F. M., Kades, G., Madeira, K., Chupel, M. U., Grossl, F. S., Souza, R., Hur Soares, B., Endrigo Ruppel da Rocha, R., da Silva Sipriano, E., … Agostinetto, L. (2024). Factors associated with the development of depression and the influence of obesity on depressive disorders: a narrative review.

Biomedicines, 12(9), 1994. https://doi.org/10.3390/BIOMEDICINES12091994

Anna, J., Elżbieta, Ś., Elżbieta M-I, Katarzyna G-J, Katarzyna B-D, Katarzyna Z. ZAG (ZincAlpha 2 Glycoprotein) serum levels in girls with anorexia nervosa. Journal of Clinical Medicine. 2023; 12(13):4245. https://doi.org/10.3390/jcm12134245

Balaz, M.; Vician, M.; Janakova, Z.; Kurdiova, T.; Surova, M.; Imrich, R.; Majercikova, Z.; Penesova, A.; Vlcek, M.; Kiss, A.; et al. Subcutaneous adipose tissue zinc-α2-glycoprotein is associated with adipose tissue and whole-body insulin sensitivity. Obesity 2014, 22, 1821–1829. https://doi.org/10.1002/oby.20764

Banaszak, M., Górna, I., & Przysławski, J. (2021). Zinc and the innovative zinc-α2-glycoprotein adipokine play an important role in lipid metabolism: a critical review. Nutrients, 13(6), 2023. https://doi.org/10.3390/NU13062023

Barraco, G. M., Luciano, R., & Manco, M. (2015). Zinc-α2-glycoprotein is associated with insulin resistance in children. Obesity, 23(1), 5–6. https://doi.org/10.1002/oby.20948

Bouchara, A., Yi, D., Pastural, M., Granjon, S., Selag, J. C., Laville, M., Arkouche, W., Pelletier, S., Fouque, D., Soulage, C. O., & Koppe, L. (2018). Serum levels of the adipokine zinc-alpha2-glycoprotein (ZAG) predict mortality in hemodialysis patients. Kidney International, 94(5), 983–992. https://doi.org/10.1016/j.kint.2018.07.019

Chan, G. C. K., Than, W. H., Kwan, B. C. H., & Szeto, C. C. (2022). Adipose and serum zinc alpha-2-glycoprotein (ZAG) expressions predict longitudinal change of adiposity, wasting and predict survival in dialysis patients. Scientific Reports, 12, 9087. https://doi.org/10.1038/s41598-022-13149-6

Choi, H., Mun, S., Joo, E. J., Lee, K. Y., Kang, H. G., & Lee, J. (2021). Serum proteomic analysis of major depressive disorder patients and their remission status: Novel biomarker set of zinc-alpha-2-glycoprotein and keratin type II cytoskeletal 1. International Journal of Biological Macromolecules, 183, 2001–2008. https://doi.org/10.1016/j.ijbiomac.2021.05.1720000

Ferrari, A. (2022). Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Psychiatry, 9(2), 137–150. https://doi.org/10.1016/S2215-0366(21)00395-3

Fleetwood, K. J., Guthrie, B., Jackson, C. A., Kelly, P. A. T., Mercer, S. W., Morales, D. R., Norrie, J. D., Smith, D. J., Sudlow, C., & Prigge, R. (2025). Depression and physical multimorbidity: A cohort study of physical health condition accrual in UK Biobank. PLOS Medicine, 22(2), e1004532. https://doi.org/10.1371/JOURNAL.PMED.1004532

Fu, X., Wang, Y., Zhao, F., Cui, R., Xie, W., Liu, Q., & Yang, W. (2023). Shared biological mechanisms of depression and obesity: focus on adipokines and lipokines. Aging, 15(12), 5917–5950. https://doi.org/10.18632/AGING.204847

Fulton, S., Décarie-Spain, L., Fioramonti, X., Guiard, B., & Nakajima, S. (2022). The menace of obesity to depression and anxiety prevalence. Trends in Endocrinology and Metabolism: TEM, 33(1), 18–35. https://doi.org/10.1016/j.tem.2021.10.005

Gebresenbet, E. A., Zegeye, S., & Biratu, T. D. (2025). Prevalence and associated factors of depression and posttraumatic stress disorder among trauma patients: multi-centered cross-sectional study. Frontiers in Psychiatry, 16, 1447232. https://doi.org/10.3389/FPSYT.2025.1447232

Gong, F. Y., Zhang, S. J., Deng, J. Y., Zhu, H. J., Pan, H., Li, N. S., & Shi, Y. F. (2009). Zinc-alpha2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue. International Journal of Obesity , 33(9), 1023–1030. https://doi.org/10.1038/ijo.2009.141

Goodwin, G. M., & Stein, D. J. (2021). Generalised anxiety disorder and depression: contemporary treatment approaches. Advances in Therapy, 38(Suppl 2), 45–51. https://doi.org/10.1007/s12325-021-01859-8 Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32(1), 50–55. https://doi.org/10.1111/j.2044-8341.1959.tb00467.x

Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23(1), 56–62. https://doi.org/10.1136/jnnp.23.1.56

Hassamal S. (2023). Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories. Frontiers in Psychiatry, 14, 1130989. https://doi.org/10.3389/fpsyt.2023.1130989

Hruby, A., & Hu, F. B. (2015). The Epidemiology of Obesity: A Big Picture. PharmacoEconomics, 33(7), 673. https://doi.org/10.1007/S40273-014-0243-X

Huang, D., Mao, X., Peng, J., Cheng, M., Bai, T., Du, M., Huang, K., Liu, B., Yang, L., Huang, K., & Zhang, F. (2019). Role of adipokine zinc-α2-glycoprotein in coronary heart disease. American Journal of Physiology. Endocrinology and Metabolism, 317(6), E1055–E1062. https://doi.org/10.1152/ajpendo.00075.2019

Kuehner, C. (2017). Why is depression more common among women than among men? The Lancet Psychiatry, 4(2), 146–158. https://doi.org/10.1016/S2215-0366(16)30263-2

Lamers, F., Milaneschi, Y., Vinkers, C. H., Schoevers, R. A., Giltay, E. J., & Penninx, B. W. J. H. (2020). Depression profilers and immuno-metabolic dysregulation: Longitudinal results from the NESDA study. Brain, Behavior, and Immunity, 88, 174–183. https://doi.org/10.1016/J.BBI.2020.04.002

Lee, Y. P., Chang, C. H., Liu, H. H., Chen, C. Y., Chen, C. Y., Hsu, C. C., Chang, C. I., Lin, Y. T., Lee, C. S., & Tsai, J. S. (2016). Plasma zinc alpha2-glycoprotein levels correlate positively with frailty severity in female elders. Medicine, 95(35), e4753. https://doi.org/10.1097/MD.0000000000004753

Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W., & Zitman, F. G. (2010). Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies. Archives of General Psychiatry, 67(3), 220–229. https://doi.org/10.1001/archgenpsychiatry.2010.2

Mannan, M., Mamun, A., Doi, S., & Clavarino, A. (2016). Prospective associations between depression and obesity for adolescent males and females- a systematic review and meta-analysis of longitudinal studies. PloS one, 11(6), e0157240. https://doi.org/10.1371/journal.pone.0157240

Mannelli, M., Gamberi, T., Magherini, F., & Fiaschi, T. (2020). The Adipokines in Cancer Cachexia. International Journal of Molecular Sciences, 21(14), 4860. https://doi.org/10.3390/ijms21144860

Martínez-Montoro, J. I., Ocaña-Wilhelmi, L., Soler-Humanes, R., Motahari-Rad, H., González-Jiménez, A., Rivas-Becerra, J., Rodríguez-Muñoz, A., Moreno-Ruiz, F. J., Tomé, M., Rodríguez-Capitán, J., García-Fuentes, E., Tinahones, F. J., Garrido-Sánchez, L., & Murri, M. (2022). Evaluation of adipose tissue zinc-alpha 2-glycoprotein gene expression and its relationship with metabolic status and bariatric surgery outcomes in patients with class iii obesity. Biomedicines, 10(7), 1502. https://doi.org/10.3390/biomedicines10071502

Pelletier, C. C., Koppe, L., Alix, P. M., Kalbacher, E., Croze, M. L., Hadj-Aissa, A., Fouque, D., Guebre-Egziabher, F., & Soulage, C. O. (2014). The relationship between renal function and plasma concentration of the cachectic factor zinc-alpha2-glycoprotein (ZAG) in adult patients with chronic kidney disease. PloS One, 9(7), e103475. https://doi.org/10.1371/journal.pone.0103475

Penninx, B. W. J. H., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013). Understanding the somatic consequences of depression: Biological mechanisms and the role of depression symptom profile. BMC Medicine, 11(1). https://doi.org/10.1186/1741-7015-11-129,

Qiu, W., Cai, X., Zheng, C., Qiu, S., Ke, H., & Huang, Y. (2021). Update on the Relationship Between Depression and Neuroendocrine Metabolism. Frontiers in Neuroscience, 15, 728810. https://doi.org/10.3389/FNINS.2021.728810/XML

Selva, D.M.; Lecube, A.; Hernandez, C.; Baena, J.A.; Fort, J.M.; Simo, R. (2009). Lower zinc-α2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insülin resistance. The Journal of Clinical Endocrinology & Metabolism. 94, 4499–4507. https://doi.org/10.1210/jc.2009-0758

Stetler, C., & Miller, G. E. (2011). Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosomatic Medicine, 73(2), 114–126. https://doi.org/10.1097/PSY.0B013E31820AD12B

Tedeschi, S., Pilotti, E., Parenti, E., Vicini, V., Coghi, P., Montanari, A., Regolisti, G., Fiaccadori, E., & Cabassi, A. (2012). Serum adipokine zinc α2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers. Metabolism: Clinical and Experimental, 61(1), 37–42. https://doi.org/10.1016/j.metabol.2011.05.011

Yazici, M. & Demir, Basaran & Tanriverdi Taskintuna, Nilgun & Karaağaoğlu, Efe & Yolaç, P.. (1998). Hamilton Anxiety Rating Scale: Interrater reliability and validity study. Türk Psikiyatri Dergisi. 9. 114-117.

Yeung, D. C., Lam, K. S., Wang, Y., Tso, A. W., & Xu, A. (2009). Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects. The Journal of Clinical Endocrinology and Metabolism, 94(7), 2531–2536. https://doi.org/10.1210/jc.2009-0058